AI Assistant
Blog
Pricing
Log In
Sign Up
Targeting hepatic glucokinase to treat diabetes with TTP399, a hepatoselective glucokinase activator
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
